Vanda Pharmaceuticals | VNDA - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 301.25B 13.1B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 37.12B 6.68B 2025-12
J&J USD 579.15B 78.91B 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Pfizer USD 148.08B 6.51B 2026-05
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Ultragenyx Pharmaceutical USD 2.04B 176M 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12
Veracyte USD 2.62B 704M 2026-05